Search filters

Filters
Clear All

Phase

  • 2
  • 4
  • 1
  • 13
  • 2
  • 31
  • 53
  • 24
  • 1
  • 4
  • 48
  • 52
  • 1
  • 2
  • 51

Found 53 Vision Loss trials

A listing of Vision Loss medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
21 years or above
All genders
Interventional
This study investigates below the knee arterial disease. The purpose of this study is to compare the effectiveness and safety of a sirolimus-coated balloon with standard angioplasty treatment.The study evaluates the potential benefits of using sirolimus-coated balloons, focusing on their safety and effectiveness in treating below the knee arterial disease.Who …
18 years or above
All genders
Phase 3
Interventional
This study investigates progressive CLAD in individuals who have undergone bilateral lung transplantation. The purpose of this study is to evaluate the safety and effectiveness of an investigational medication in comparison to a placebo.The study focuses on assessing how well the investigational medication works and its safety in patients who …
18 years - 99 years
All genders
Phase 1
The primary objectives are to determine the pharmacokinetic (PK) and pharmacodynamic (PD) response of dorzagliatin 75 mg twice daily following 7-day administration in individuals with PI-CF and abnormal glucose tolerance (EGI, IGT or CFRD) when compared to 7-day administration of placebo according to a randomized, double-blind cross-over study design. The …
55 years - 85 years
All genders
Phase 2
To assess the effect of donanemab versus placebo on cognitive and functional progression in participants with established alpha-synuclein and amyloid co-pathology
18 years or above
All genders
Interventional
This study investigates whether additional regional nerve blocks can reduce pain and anxiety in adults undergoing Mohs micrographic surgery for skin cancers on the face and scalp. Participants will be randomly assigned to one of two study arms: one receiving a placebo nerve block with sterile saline and the other …
18 years or above
Accepts healthy volunteer
Female
This study investigates the use of trained detection dogs and artificial intelligence (AI) to identify breast cancer from a person's breath. The purpose of this study is to understand if this method can accurately detect breast cancer in women who are scheduled for routine screening, such as mammograms, ultrasounds, or …
EA2192 APOLLO: A Randomized Phase II Double-Blind Study of Olaparib versus Placebo Following Curative Intent Therapy in Patients with Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
18 years or above
All genders
Phase 2
Interventional
This study investigates the effectiveness of an investigational medication following surgery and chemotherapy in patients with pancreatic cancer who have specific genetic mutations. The study focuses on patients whose cancer has been surgically removed and who have a mutation in the BRCA1, BRCA2, or PALB2 genes. These genes are known …
18 years - 80 years
All genders
Phase 2
Interventional
This study investigates the use of an investigational medication to treat Adjustment Disorder (AjD) in patients with cancer and other medical conditions such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson's Disease (PD), or Idiopathic Pulmonary Fibrosis (IPF). The purpose of this study is to assess whether a single …
18 years or above
All genders
Phase 3
Interventional
This study investigates the effects of adding an investigational medication to an existing treatment with ruxolitinib for patients with myelofibrosis. The purpose of this study is to determine if the investigational medication can provide more benefits than ruxolitinib alone for patients who have not responded well to ruxolitinib by itself.Participants …
18 years or above
All genders
Phase 3
Interventional
This study investigates the use of investigational medications for treating metastatic non-small cell lung cancer (mNSCLC) in patients whose tumors express PD-L1. The purpose of this study is to compare the effectiveness and safety of two treatments: one investigational medication and a standard treatment, pembrolizumab. Participants will be randomly assigned …